TSXV/DHB (TSXV/DHB)

TSX Venture Exchange: TSXV/DHB · CAD

CA$0.08

+0.00 (0.0%)· Recorded snapshot

Market cap	2.5M
Revenue (ttm)	8.6M
Net income (ttm)	-2.3M
EPS (ttm)	-CA$0.07
Shares out	31.3M
Volume	0
Beta	0.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.6M
Net income (ttm): -2.3M
EPS (ttm): -CA$0.07
Market cap: 2.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROE-69.8

P25 -104.1P50 -30P75 6.7

ROIC-23.4

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All TSXV/DHB indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

CAD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-26
Employees change	19
Employees growth	237.5%
Enterprise value	CAD 2.1M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA24703H2019
Last earnings date	2026-02-20
Last refreshed	2026-10-29
Last stock split date	2025-02-21
Last stock split type	Reverse
Market cap	CAD 2.5M
Next earnings date	2026-11-26
Price	CAD 0.08
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	tsxv/DHB
Website	https://delivrahealthbrands.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-90.13%
EV/Sales	0.24x
FCF / EV yield	-30.94%
FCF yield	-25.47%
Industry forward P/E	34.4x
P/B ratio	1.12x
P/S ratio	0.29x
Price / tangible book value	1.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-23.85%
EBITDA margin	-23.54%
Gross margin	38.65%
Operating margin	-23.85%
Pretax margin	-26.12%
Profit margin	-26.12%
ROA	-15.56%
ROA (5Y)	-11.49%
ROCE	-48.07%
ROE	-69.75%
ROE (5Y)	-37%
ROIC	-23.41%
SBC / revenue	1.49%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth (Q)	-55.42%
Gross profit growth	-50.8%
Gross profit growth (Q)	-76.39%
Gross profit growth 3Y	-11.57%
Gross profit growth 5Y	11.69%
Net income growth years	0
OCF growth (Q)	-55.42%
Revenue growth	-35.46%
Revenue growth (Q)	-60.03%
Revenue growth (QoQ)	39.7%
Revenue growth 10Y	42.69%
Revenue growth 3Y	-4.12%
Revenue growth 5Y	1.64%
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 27,000
EBIT	CAD -2.1M
EBITDA	CAD -2M
EPS	CAD -0.07
FCF per share	CAD -0.02
Financing cash flow	CAD -13,000
Free cash flow	CAD -637,000
Free cash flow minus SBC	CAD -766,000
Gross profit	CAD 3.3M
Net borrowing	CAD -13,000
Net cash flow	CAD -449,000
Net income	CAD -2.3M
Operating cash flow minus SBC	CAD -766,000
Operating income	CAD -2.1M
Revenue	CAD 8.6M
Stock-based compensation	CAD 129,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD 0.07
Debt / equity	1.08
Interest coverage	-12.63
Long-term assets	CAD 0
Long-term liabilities	CAD 2.1M
Net cash (debt)	CAD 442,000
Net cash / market cap	17.67%
Net cash growth	-62.83%
Net debt / equity	-0.2
Piotroski F-Score	1
Shareholders' equity	CAD 2.2M
Tangible book value	CAD 2.2M
Tangible book value per share	CAD 0.07
Total assets	CAD 6.9M
Total cash	CAD 2.9M
Total debt	CAD 2.4M
Total liabilities	CAD 4.7M
WACC	7.26%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.04
Current assets	CAD 6.9M
Current liabilities	CAD 2.6M
Current ratio	2.62
Inventory turnover	2.18
Net working capital	CAD 1.8M
Quick ratio	1.78
Working capital	CAD 4.3M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.13
1D price change	0%
1M price change	-11.11%
1M total return	-11.11%
1W price change	-15.79%
1W total return	-15.79%
1Y price change	-69.23%
1Y return CAGR	-69.26%
1Y total return	-69.23%
20-day SMA	CAD 0.09
200-day SMA	CAD 0.16
3M price change	-11.11%
3M total return	-11.11%
3Y price change	-46.67%
3Y return CAGR	-18.9%
3Y total return	-46.67%
50-day SMA	CAD 0.10
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.35
52-week high date	2025-11-07
52-week low	CAD 0.07
52-week low date	2026-10-07
5Y price change	-89.33%
5Y return CAGR	-36.09%
5Y total return	-89.33%
6M price change	-46.67%
6M total return	-46.67%
All-time high	CAD 22.00
All-time high date	2018-01-08
All-time low	CAD 0.07
All-time low date	2026-10-07
Average true range (ATR)	CAD 0.01
Average volume	29.2K
Beta (1Y)	0.63
Beta (2Y)	1.85
Beta (5Y)	0.88
Change from 52-week high	-77.14%
Change from 52-week low	14.29%
Change from all-time high	-99.64%
Change from all-time low	14.29%
Monthly RSI	35.37
Previous close	CAD 0.08
Price vs 150-day SMA	-37.84%
Price vs 20-day SMA	-12.57%
Price vs 200-day SMA	-49.59%
Price vs 50-day SMA	-19.44%
Relative volume	0.04
RSI	42.6
Sharpe ratio	-0.18
Sharpe ratio (3Y)	0.71
Sharpe ratio (5Y)	0.5
Sortino ratio	-0.23
Sortino ratio (3Y)	1.24
Sortino ratio (5Y)	0.87
Volume	0
Weekly RSI	39.86
YTD price change	-60.98%
YTD total return	-60.98%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24.4M
Shares change (QoQ)	0%
Shares held by insiders	22.05%
Shares held by institutions	0.15%
Shares outstanding	31.3M

Deeper analysis on TSXV/DHB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/DHB report

Is a complete TSXV/DHB research report available?

No complete published report is available for tsxv/DHB (TSXV/DHB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/DHB (TSXV/DHB)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/DHB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/DHB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on TSXV/DHB

Frequently asked questions